Lv3
392 积分 2022-06-21 加入
Ablation of FAS confers allogeneic CD3– CAR T cells with resistance to rejection by T cells and natural killer cells
3天前
已完结
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms
16天前
已完结
Engineering a solution for allogeneic CAR-T rejection
17天前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
18天前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
25天前
已完结
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity
1个月前
已完结
Combined Genetic Ablation of CD54 and CD58 in CAR Engineered Cytotoxic Lymphocytes Effectively Averts Allogeneic Immune Cell Rejection
1个月前
已完结
Combined Genetic Ablation of CD54 and CD58 in CAR Engineered Cytotoxic Lymphocytes Effectively Averts Allogeneic Immune Cell Rejection
1个月前
已关闭
Combined Genetic Ablation of CD54 and CD58 in CAR Engineered Cytotoxic Lymphocytes Effectively Averts Allogeneic Immune Cell Rejection
1个月前
已关闭
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
1个月前
已完结
皖公网安备34019202002308
